List of Excipients in API EZETIMIBE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing EZETIMIBE
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Rebel Distributors Corp | ZETIA | ezetimibe | 21695-778 | CELLULOSE, MICROCRYSTALLINE | |
Rebel Distributors Corp | ZETIA | ezetimibe | 21695-778 | CROSCARMELLOSE SODIUM | |
Rebel Distributors Corp | ZETIA | ezetimibe | 21695-778 | LACTOSE MONOHYDRATE | |
Rebel Distributors Corp | ZETIA | ezetimibe | 21695-778 | MAGNESIUM STEARATE | |
Rebel Distributors Corp | ZETIA | ezetimibe | 21695-778 | POVIDONE | |
Rebel Distributors Corp | ZETIA | ezetimibe | 21695-778 | SODIUM LAURYL SULFATE | |
Physicians Total Care Inc | ZETIA | ezetimibe | 54868-4719 | CELLULOSE, MICROCRYSTALLINE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing EZETIMIBE
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Actavis Pharma Inc | ezetimibe | 0591-3713 | CELLULOSE, MICROCRYSTALLINE |
Actavis Pharma Inc | ezetimibe | 0591-3713 | CROSCARMELLOSE SODIUM |
Actavis Pharma Inc | ezetimibe | 0591-3713 | CROSPOVIDONE |
Actavis Pharma Inc | ezetimibe | 0591-3713 | HYPROMELLOSE 2910 |
Actavis Pharma Inc | ezetimibe | 0591-3713 | LACTOSE MONOHYDRATE |
Actavis Pharma Inc | ezetimibe | 0591-3713 | MAGNESIUM STEARATE |
Actavis Pharma Inc | ezetimibe | 0591-3713 | SODIUM LAURYL SULFATE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for EZETIMIBE
Excipient focus: ANHYDROUS CITRIC ACID
EZETIMIBE drug variants containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | ezetimibe | 10135-787 |
Orient Pharma Co Ltd | ezetimibe | 76333-170 |
Actavis Pharma Inc | ezetimibe and simvastatin | 45963-565 |
Actavis Pharma Inc | ezetimibe and simvastatin | 45963-566 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ezetimibe | 0591-3713 |
NCS HealthCare of KY LLC dba Vangard Labs | ezetimibe | 0615-8300 |
Sandoz Inc | ezetimibe | 0781-5690 |
Major Pharmaceuticals | ezetimibe | 0904-6664 |
Major Pharmaceuticals | ezetimibe | 0904-7103 |
NorthStar Rx LLC | ezetimibe | 16714-813 |
Accord Healthcare Inc | ezetimibe | 16729-433 |
>Company | >Ingredient | >NDC |
Excipient focus: ASCORBIC ACID
EZETIMIBE drug variants containing ASCORBIC ACID
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ezetimibe and simvastatin | 45963-565 |
Actavis Pharma Inc | ezetimibe and simvastatin | 45963-566 |
Aurobindo Pharma Limited | ezetimibe and simvastatin | 59651-835 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing ASCORBIC ACID
Excipient focus: BUTYLATED HYDROXYANISOLE
EZETIMIBE drug variants containing BUTYLATED HYDROXYANISOLE
EZETIMIBE drug variants not containing BUTYLATED HYDROXYANISOLE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
EZETIMIBE drug variants containing CELLULOSE, MICROCRYSTALLINE
EZETIMIBE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
EZETIMIBE drug variants containing CITRIC ACID MONOHYDRATE
EZETIMIBE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: CROSCARMELLOSE SODIUM
EZETIMIBE drug variants containing CROSCARMELLOSE SODIUM
EZETIMIBE drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
EZETIMIBE drug variants containing CROSPOVIDONE
EZETIMIBE drug variants not containing CROSPOVIDONE
Excipient focus: FERRIC OXIDE RED
EZETIMIBE drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ezetimibe and simvastatin | 45963-565 |
Actavis Pharma Inc | ezetimibe and simvastatin | 45963-566 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
EZETIMIBE drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ezetimibe and simvastatin | 45963-565 |
Actavis Pharma Inc | ezetimibe and simvastatin | 45963-566 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
EZETIMIBE drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ezetimibe and simvastatin | 45963-565 |
Actavis Pharma Inc | ezetimibe and simvastatin | 45963-566 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYPROMELLOSE
EZETIMIBE drug variants containing HYPROMELLOSE
EZETIMIBE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
EZETIMIBE drug variants containing HYPROMELLOSE 2208
EZETIMIBE drug variants not containing HYPROMELLOSE 2208
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ezetimibe | 0591-3713 |
Sandoz Inc | ezetimibe | 0781-5690 |
Major Pharmaceuticals | ezetimibe | 0904-6664 |
Major Pharmaceuticals | ezetimibe | 0904-7103 |
Marlex Pharmaceuticals Inc | ezetimibe | 10135-787 |
Accord Healthcare Inc | ezetimibe | 16729-433 |
Rebel Distributors Corp | ezetimibe | 21695-778 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
EZETIMIBE drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ezetimibe | 0591-3713 |
Sandoz Inc | ezetimibe | 0781-5690 |
Camber Pharmaceuticals Inc | ezetimibe | 31722-628 |
Bryant Ranch Prepack | ezetimibe | 63629-7413 |
REMEDYREPACK INC | ezetimibe | 70518-3334 |
Proficient Rx LP | ezetimibe | 71205-145 |
Bryant Ranch Prepack | ezetimibe | 71335-0933 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
EZETIMIBE drug variants containing HYPROMELLOSES
EZETIMIBE drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
EZETIMIBE drug variants containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
A-S Medication Solutions | ezetimibe and simvastatin | 50090-4772 |
Ascend Laboratories LLC | ezetimibe and simvastatin | 67877-507 |
REMEDYREPACK INC | ezetimibe and simvastatin | 70518-1955 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
EZETIMIBE drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ezetimibe | 0591-3713 |
NCS HealthCare of KY LLC dba Vangard Labs | ezetimibe | 0615-8300 |
Sandoz Inc | ezetimibe | 0781-5690 |
Major Pharmaceuticals | ezetimibe | 0904-6664 |
Major Pharmaceuticals | ezetimibe | 0904-7103 |
NorthStar Rx LLC | ezetimibe | 16714-813 |
Accord Healthcare Inc | ezetimibe | 16729-433 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | ezetimibe | 10135-787 |
Orient Pharma Co Ltd | ezetimibe | 76333-170 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
EZETIMIBE drug variants containing MAGNESIUM STEARATE
EZETIMIBE drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
EZETIMIBE drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Marlex Pharmaceuticals Inc | ezetimibe | 10135-787 |
Orient Pharma Co Ltd | ezetimibe | 76333-170 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | ezetimibe | 0591-3713 |
NCS HealthCare of KY LLC dba Vangard Labs | ezetimibe | 0615-8300 |
Sandoz Inc | ezetimibe | 0781-5690 |
Major Pharmaceuticals | ezetimibe | 0904-6664 |
Major Pharmaceuticals | ezetimibe | 0904-7103 |
NorthStar Rx LLC | ezetimibe | 16714-813 |
Accord Healthcare Inc | ezetimibe | 16729-433 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
EZETIMIBE drug variants containing MICROCRYSTALLINE CELLULOSE 101
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | ezetimibe | 31722-628 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: POLYSORBATE 80
EZETIMIBE drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Accord Healthcare Inc | ezetimibe | 16729-433 |
REMEDYREPACK INC | ezetimibe | 70518-3819 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing POLYSORBATE 80
Excipient focus: POVIDONE
EZETIMIBE drug variants containing POVIDONE
EZETIMIBE drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
EZETIMIBE drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Accord Healthcare Inc | ezetimibe | 16729-433 |
REMEDYREPACK INC | ezetimibe | 70518-3819 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing POVIDONE K30
Excipient focus: PROPYL GALLATE
EZETIMIBE drug variants containing PROPYL GALLATE
EZETIMIBE drug variants not containing PROPYL GALLATE
Excipient focus: SILICON DIOXIDE
EZETIMIBE drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | ezetimibe | 0904-6664 |
Camber Pharmaceuticals Inc | ezetimibe | 31722-628 |
Apotex Corp | ezetimibe | 60505-2945 |
Bryant Ranch Prepack | ezetimibe | 71335-1354 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM LAURETH-12 SULFATE
EZETIMIBE drug variants containing SODIUM LAURETH-12 SULFATE
Company | Ingredient | NDC |
---|---|---|
A-S Medication Solutions | ezetimibe | 50090-3087 |
AvPAK | ezetimibe | 50268-298 |
Amneal Pharmaceuticals NY LLC | ezetimibe | 69238-1154 |
Bryant Ranch Prepack | ezetimibe | 71335-0684 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing SODIUM LAURETH-12 SULFATE
Excipient focus: SODIUM LAURYL SULFATE
EZETIMIBE drug variants containing SODIUM LAURYL SULFATE
EZETIMIBE drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
EZETIMIBE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
A-S Medication Solutions | ezetimibe | 50090-7338 |
A-S Medication Solutions | ezetimibe | 50090-7339 |
ScieGen Pharmaceuticals Inc | ezetimibe | 50228-379 |
Glenmark Pharmaceuticals Inc USA | ezetimibe | 68462-226 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STEARYL FUMARATE
EZETIMIBE drug variants containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Zydus Pharmaceuticals USA Inc | ezetimibe | 68382-773 |
Zydus Lifesciences Limited | ezetimibe | 70771-1109 |
Quallent Pharmaceuticals Health LLC | ezetimibe | 82009-024 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STARCH, CORN
EZETIMIBE drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Ohm Laboratories Inc | ezetimibe | 51660-200 |
Golden State Medical Supply Inc | ezetimibe | 60429-982 |
Zydus Pharmaceuticals USA Inc | ezetimibe | 68382-773 |
Zydus Lifesciences Limited | ezetimibe | 70771-1109 |
Quallent Pharmaceuticals Health LLC | ezetimibe | 82009-024 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing STARCH, CORN
Excipient focus: WATER
EZETIMIBE drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
A-S Medication Solutions | ezetimibe and simvastatin | 50090-4772 |
Ascend Laboratories LLC | ezetimibe and simvastatin | 67877-507 |
REMEDYREPACK INC | ezetimibe and simvastatin | 70518-1955 |
>Company | >Ingredient | >NDC |
EZETIMIBE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.